"A conscious control over life and my emotions:" mindfulness practice and healthy young people. A qualitative study.

K. Monshat,B. Khong,C. Hassed,D. Vella-Brodrick,J. Norrish,J. Burns,H. Herrman

DOI: https://doi.org/10.1016/j.jadohealth.2012.09.008

IF: 7.898

2013-05-01

Journal of Adolescent Health

Abstract:

What problem does this paper attempt to address?

Space Time-Based Optofluidic Imaging Analyser for Intelligent Blood Coagulation Diagnosis

Longfei Chen,Le Yu,Yantong Liu,Hongshan Xu,Linlu Ma,Pengfu Tian,Jiaomeng Zhu,Fang Wang,Kezhen Yi,Hui Xiao,Fuling Zhou,Yi Yang,Yanxiang Cheng,Long Bai,Fubing Wang,Yimin Zhu

DOI: https://doi.org/10.2139/ssrn.4069030

2022-01-01

Abstract:The coagulation composite index (CI) is a key parameter for comprehensive assessment of blood coagulation kinetics, which has significant meaning for guiding surgery, transfusion, and patient recovery treatment, et al. Herein, we innovatively propose a smart optofluidic medical device via artificial intelligent assisted space time-based optical clotting imaging analysing for accurate and convenient blood coagulation diagnosis. The developed space time-based imaging system enables continuous imaging capture in blood clotting, the smartphone based edge computing was designed for continuous and accurate optically reconstructed clotting biophysical properties (clotting area and gray value) acquisition and recording. The time-based recorded data with differential computation was then imported into a cloud-based neural network for coagulation diagnosis. In this work, the 119 clinical blood samples (73 health, CI value: -3-3; 28 hypocoagulation, CI value: 3) were set for space time-based neural network diagnostic model development. And the strong performance of this system has been validated via a double-blind 30 clinical samples test comparison between thromboelastography (TEG) instrument and this system, the results show that the system exhibits an excellent diagnostic accuracy of 100%. This work provides a promising method for low testing cost, portable and smart coagulation diagnosis with potential economic and social benefits.
Space-time-regulated Imaging Analyzer for Smart Coagulation Diagnosis.

Longfei Chen,Le Yu,Yantong Liu,Hongshan Xu,Linlu Ma,Pengfu Tian,Jiaomeng Zhu,Fang Wang,Kezhen Yi,Hui Xiao,Fuling Zhou,Yi Yang,Yanxiang Cheng,Long Bai,Fubing Wang,Yimin Zhu

DOI: https://doi.org/10.1016/j.xcrm.2022.100765

IF: 16.988

2022-01-01

Cell Reports Medicine

Abstract:The development of intelligent blood coagulation diagnoses is awaited to meet the current need for large clinical time-sensitive caseloads due to its efficient and automated diagnoses. Herein, a method is reported and validated to realize it through artificial intelligence (AI)-assisted optical clotting biophysics (OCB) properties identification. The image differential calculation is used for precise acquisition of OCB properties with elimination of initial differences, and the strategy of space-time regulation allows on-demand space time OCB properties identification and enables diverse blood function diagnoses. The integrated applications of smartphones and cloud computing offer a user-friendly automated analysis for accurate and convenient diagnoses. The prospective assays of clinical cases (n = 41) show that the system realizes 97.6%, 95.1%, and 100% accuracy for coagulation factors, fibrinogen function, and comprehensive blood coagulation diagnoses, respectively. This method should enable more low-cost and convenient diagnoses and provide a path for potential diagnostic-markers finding.
Deep learning, 3D ultrastructural analysis reveals quantitative differences in platelet and organelle packing in COVID-19/SARSCoV2 patient-derived platelets

Sagar S. Matharu,Cassidy S. Nordmann,Kurtis R. Ottman,Rahul Akkem,Douglas Palumbo,Denzel R. D. Cruz,Kenneth Campbell,Gail Sievert,Jamie Sturgill,James Z. Porterfield,Smita Joshi,Hammodah R. Alfar,Chi Peng,Irina D. Pokrovskaya,Jeffrey A. Kamykowski,Jeremy P. Wood,Beth Garvy,Maria A. Aronova,Sidney W. Whiteheart,Richard D. Leapman,Brian Storrie

DOI: https://doi.org/10.1080/09537104.2023.2264978

2023-11-07

Platelets

Abstract:Platelets contribute to COVID-19 clinical manifestations, of which microclotting in the pulmonary vasculature has been a prominent symptom. To investigate the potential diagnostic contributions of overall platelet morphology and their α-granules and mitochondria to the understanding of platelet hyperactivation and micro-clotting, we undertook a 3D ultrastructural approach. Because differences might be small, we used the high-contrast, high-resolution technique of focused ion beam scanning EM (FIB-SEM) and employed deep learning computational methods to evaluate nearly 600 individual platelets and 30 000 included organelles within three healthy controls and three severely ill COVID-19 patients. Statistical analysis reveals that the α-granule/mitochondrion-to-plateletvolume ratio is significantly greater in COVID-19 patient platelets indicating a denser packing of organelles, and a more compact platelet. The COVID-19 patient platelets were significantly smaller -by 35% in volume - with most of the difference in organelle packing density being due to decreased platelet size. There was little to no 3D ultrastructural evidence for differential activation of the platelets from COVID-19 patients. Though limited by sample size, our studies suggest that factors outside of the platelets themselves are likely responsible for COVID-19 complications. Our studies show how deep learning 3D methodology can become the gold standard for 3D ultrastructural studies of platelets.

cell biology,hematology
IP-10 and MCP-1 As Biomarkers Predicting Disease Severity of COVID-19

Yu Chen,Jinglan Wang,Chenxi Liu,Longxiang Su,Dong Zhang,Junping Fan,Yanli Yang,Meng Xiao,Jing Xie,Yingchun Xu,Yongzhe Li,Shuyang Zhang

DOI: https://doi.org/10.2139/ssrn.3619756

2020-01-01

Abstract:Background: COVID-19 is a viral respiratory disease caused by the severe acute respiratory Syndrome-Coronavirus type 2 (SARS-CoV-2). Patients with this disease may be more prone to venous or arterial thrombosis because of the activation of many factors involved in it, including inflammation, platelet activation and endothelial dysfunction. Therefore, this study focused on coagulation and thrombosis-related indicators in COVID-19, with the hope to find biomarkers that can predict patients' outcome. Methods: This is a retrospective single-center study involving 74 severe and critically ill COVID-19 patients recruited from the ICU department of the Tongji Hospital in Wuhan, China. The patients were divided into two groups: severe patients and critically ill patients. The serum IP-10, MCP-1 and MIP1a level in both groups was detected using the enzyme-linked immunosorbent assay (ELISA) kit. The clinical symptoms, laboratory test results and the outcome of COVID-19 patients were retrospectively analyzed. Results: The serum IP-10 and MCP-1 level in critically ill patients was significantly higher than that in severe patients ( P <0.001). However, no statistical difference in MIP1a between the two groups was found. The analysis of dynamic changes showed that these indicators remarkably increased in patients with poor prognosis. Since the selected patients were severe or critically ill, no significant difference was observed between survival and death. Conclusions: IP-10 and MCP-1 are biomarkers predicting the severity of COVID-19 disease and could be related to the risk of death in COVID-19 patients. In addition, anti-IP-10 antibody treatment may represent a new approach in COVID-19 patients, especially the ones with thrombotic events.Funding Statement: This research was supported by the grants from the National Natural Science Foundation of China (Grants 81671618 and 81871302), CAMS Innovation Fund for Medical Sciences (CIFMS 2017-I2M-3- 001 and CIFMS 017-I2M-B&R-01).Declaration of Interests: The authors declare no conflicts of interest.Ethics Approval Statement: This study was approved by the Ethics Committee of the Peking Union Medical College Hospital, and the informed consent to participate to this study was provided by all the enrolled patients or their families.
Finding and following: a deep learning-based pipeline for tracking platelets during thrombus formation in vivo and ex vivo

Abigail S. McGovernPia LarssonVolga TarlacNatasha SetiabaktiLeila Shabani MashcoolJustin R. HamiltonNiklas BoknäsJuan Nunez-Iglesias1 Department of Anatomy and Developmental Biology,Biomedicine Discovery Institute,Monash University,Melbourne,Australia2 Australian Centre for Blood Diseases,Monash University,Melbourne,Australia3 Department of Biomedical and Clinical Sciences,Linköping University,Linköping,Sweden

DOI: https://doi.org/10.1080/09537104.2024.2344512

2024-05-09

Platelets

Abstract:The last decade has seen increasing use of advanced imaging techniques in platelet research. However, there has been a lag in the development of image analysis methods, leaving much of the information trapped in images. Herein, we present a robust analytical pipeline for finding and following individual platelets over time in growing thrombi. Our pipeline covers four steps: detection, tracking, estimation of tracking accuracy, and quantification of platelet metrics. We detect platelets using a deep learning network for image segmentation, which we validated with proofreading by multiple experts. We then track platelets using a standard particle tracking algorithm and validate the tracks with custom image sampling — essential when following platelets within a dense thrombus. We show that our pipeline is more accurate than previously described methods. To demonstrate the utility of our analytical platform, we use it to show that in vivo thrombus formation is much faster than that ex vivo . Furthermore, platelets in vivo exhibit less passive movement in the direction of blood flow. Our tools are free and open source and written in the popular and user-friendly Python programming language. They empower researchers to accurately find and follow platelets in fluorescence microscopy experiments. In this paper we describe computational tools to find and follow individual platelets in blood clots recorded with fluorescence microscopy. Our tools work in a diverse range of conditions, both in living animals and in artificial flow chamber models of thrombosis. Our work uses deep learning methods to achieve excellent accuracy. We also provide tools for visualizing data and estimating error rates, so you don't have to just trust the output. Our workflow measures platelet density, shape, and speed, which we use to demonstrate differences in the kinetics of clotting in living vessels versus a synthetic environment. The tools we wrote are open source, written in the popular Python programming language, and freely available to all. We hope they will be of use to other platelet researchers.

cell biology,hematology
Convolutional neuronal network for identifying single‐cell‐platelet–platelet‐aggregates in human whole blood using imaging flow cytometry

Broder Poschkamp,Sander Bekeschus

DOI: https://doi.org/10.1002/cyto.a.24829

IF: 4.714

2024-02-17

Cytometry Part A

Abstract:Imaging flow cytometry is an attractive method to investigate individual cells by optical properties. However, imaging flow cytometry applications with clinical relevance are scarce so far. Platelet aggregation naturally occurs during blood coagulation to form a clot. However, aberrant platelet aggregation is associated with cardiovascular disease under steady‐state conditions in the blood. Several types of so‐called antiplatelet drugs are frequently described to reduce the risk of stroke or cardiovascular diseases. However, an efficient monitoring method is missing to identify the presence and frequency of platelet–platelet aggregates in whole blood on a single cell level. In this work, we employed imaging flow cytometry to identify fluorescently labeled platelets in whole blood with a conditional gating strategy. Images were post‐processed and aligned. A convolutional neural network was designed to identify platelet–platelet aggregates of two, three, and more than three platelets, and results were validated against various data set properties. In addition, the neural network excluded erythrocyte–platelet aggregates from the results. Based on the results, a parameter for detecting platelet–platelet aggregates, the weighted platelet aggregation, was developed. If employed on a broad scale with proband and patient samples, our method could aid in building a future diagnostic marker for cardiovascular disease and monitoring parameters to optimize drug prescriptions in such patient groups.

cell biology,biochemical research methods
Finding and Following: A deep learning-based pipeline for tracking platelets during thrombus formation and

Abigail S. McGovern,Pia Larsson,Volga Tarlac,Natasha Setiabakti,Leila Shabani Mashcool,Justin R. Hamilton,Niklas Boknäs,Juan Nunez-Iglesias

DOI: https://doi.org/10.1101/2023.10.02.560609

2024-02-08

Abstract:The last decade has seen increasing use of advanced imaging techniques in platelet research. However, there has been a lag in the development of image analysis methods, leaving much of the information trapped in images. Herein, we present a robust analytical pipeline for finding and following individual platelets over time in growing thrombi. Our pipeline covers four steps: detection, tracking, estimation of tracking accuracy, and quantification of platelet metrics. We detect platelets using a deep learning network for image segmentation, which we validated with proofreading by multiple experts. We then track platelets using a standard particle tracking algorithm and validate the tracks with custom image sampling — essential when following platelets within a dense thrombus. We show that our pipeline is more accurate than previously described methods. To demonstrate the utility of our analytical platform, we use it to show that thrombus formation is much faster than that . Furthermore, platelets exhibit less passive movement in the direction of blood flow. Our tools are free and open source and written in the popular and user-friendly Python programming language. They empower researchers to accurately find and follow platelets in fluorescence microscopy experiments.x

Bioinformatics
Circulating cellular clusters are associated with thrombotic complications and clinical outcomes in COVID-19

Ander Dorken-Gallastegi,Yao Lee,Guansheng Li,He Li,Leon Naar,Xuejin Li,Ting Ye,Elizabeth Van Cott,Rachel Rosovsky,David Gregory,Ronald Tompkins,George Karniadakis,Haytham MA. Kaafarani,George C. Velmahos,Jarone Lee,Galit H. Frydman

DOI: https://doi.org/10.1016/j.isci.2023.107202

IF: 5.8

2023-01-01

iScience

Abstract:We sought to study the role of circulating cellular clusters (CCC) -such as circulating leukocyte clusters (CLCs), platelet-leukocyte aggregates (PLA), and platelet-erythrocyte aggregates (PEA)- in the immunothrombotic state induced by COVID-19. Forty-six blood samples from 37 COVID-19 patients and 12 samples from healthy controls were analyzed with imaging flow cytometry. Patients with COVID-19 had significantly higher levels of PEAs (p value<0.001) and PLAs (p value = 0.015) compared to healthy controls. Among COVID-19 patients, CLCs were correlated with thrombotic complications (p value = 0.016), vasopressor need (p value = 0.033), acute kidney injury (p value = 0.027), and pneumonia (p value = 0.036), whereas PEAs were associated with positive bacterial cultures (p value = 0.033). In predictive in silico simulations, CLCs were more likely to result in microcirculatory obstruction at low flow velocities (<= 1 mm/s) and at higher branching angles. Further studies on the cellular component of hyperinflammatory prothrombotic states may lead to the identification of novel biomarkers and drug targets for inflammation-related thrombosis.
Qualitative classification of thrombus images as a way to improve quantitative analysis of thrombus formation in flow chamber assays

Piotr Kamola,Tomasz Przygodzki

DOI: https://doi.org/10.1371/journal.pone.0299202

IF: 3.7

2024-03-11

PLoS ONE

Abstract:Background Thrombus formation in vitro under flow conditions is one of the most widely used methods to study haemostasis and to evaluate the activity of potential antithrombotic compounds. Assessment of the results of these experiments is often based on a quantification of microscopic images of thrombi. In a majority of reported analysis all thrombi visualised in an image are quantified as one homogenous class. In some protocols, qualitative assessment of thrombi morphology based on a visual comparison of evaluated images with representative images of predefined classes of thrombi are performed by experienced analysts. In presented paper we show how the quantitative analysis can be improved by classification of thrombi on the basis of defined morphological features prior to quantification and we suggest that machine learning-based approach can improve this way of analysis. Methods We tested the applicability of machine learning-based segmentation and classification of thrombi images to improve the outcome of quantification of the results of flow chamber assays. For this, we used the public domain machine learning software Ilastik for bioimage analysis developed at the European Molecular Biology Laboratory. A model was trained to distinguish two classes of thrombi based on certain morphological features which apparently correspond to the stage of thrombus development. Thrombi formed in the presence of a model antiplatelet compound—abciximab or in control conditions were quantified with the use of this model and the results were compared to quantification where all thrombi were quantified as a homogenous class. Results Machine learning-based analysis was capable of effective distinguishing of two classes of morphologically distinct platelet aggregates. The use of the model which segmented and quantified only the objects recognized as compacted structures provided results which better mirrored the actual effect of an antiplatelet treatment than quantification based on all structures. Conclusions Classification of thrombi enabled by machine learning increases the relevance of quantitative information and allows better evaluation of the results of in vitro thrombosis assays.

multidisciplinary sciences
Advancing Ischemic Stroke Diagnosis: A Novel Two-Stage Approach for Blood Clot Origin Identification

Koushik Sivarama Krishnan,P. J. Joe Nikesh,Swathi Gnanasekar,Karthik Sivarama Krishnan

2024-01-06

Abstract:An innovative two-stage methodology for categorizing blood clot origins is presented in this paper, which is important for the diagnosis and treatment of ischemic stroke. First, a background classifier based on MobileNetV3 segments big whole-slide digital pathology images into numerous tiles to detect the presence of cellular material. After that, different pre-trained image classification algorithms are fine-tuned to determine the origin of blood clots. Due to complex blood flow dynamics and limitations in conventional imaging methods such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, identifying the sources of blood clots is a challenging task. Although these techniques are useful for identifying blood clots, they are not very good at determining how they originated. To address these challenges, our method makes use of robust computer vision models that have been refined using information from whole-slide digital pathology images. Out of all the models tested, the PoolFormer \cite{yu2022metaformer} performs better than the others, with 93.4\% accuracy, 93.4\% precision, 93.4\% recall, and 93.4\% F1-score. Moreover, it achieves the good weighted multi-class logarithmic loss (WMCLL) of 0.4361, which emphasizes how effective it is in this particular application. These encouraging findings suggest that our approach can successfully identify the origin of blood clots in a variety of vascular locations, potentially advancing ischemic stroke diagnosis and treatment approaches.

Image and Video Processing,Computer Vision and Pattern Recognition
Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98

Romy de Laat-Kremers,Raf De Jongh,Marisa Ninivaggi,Aernoud Fiolet,Rob Fijnheer,Jasper Remijn,Bas de Laat

DOI: https://doi.org/10.3389/fimmu.2022.977443

2022-09-28

Abstract:Thrombosis is a major clinical complication of COVID-19 infection. COVID-19 patients show changes in coagulation factors that indicate an important role for the coagulation system in the pathogenesis of COVID-19. However, the multifactorial nature of thrombosis complicates the prediction of thrombotic events based on a single hemostatic variable. We developed and validated a neural net for the prediction of COVID-19-related thrombosis. The neural net was developed based on the hemostatic and general (laboratory) variables of 149 confirmed COVID-19 patients from two cohorts: at the time of hospital admission (cohort 1 including 133 patients) and at ICU admission (cohort 2 including 16 patients). Twenty-six patients suffered from thrombosis during their hospital stay: 19 patients in cohort 1 and 7 patients in cohort 2. The neural net predicts COVID-19 related thrombosis based on C-reactive protein (relative importance 14%), sex (10%), thrombin generation (TG) time-to-tail (10%), α2-Macroglobulin (9%), TG curve width (9%), thrombin-α2-Macroglobulin complexes (9%), plasmin generation lag time (8%), serum IgM (8%), TG lag time (7%), TG time-to-peak (7%), thrombin-antithrombin complexes (5%), and age (5%). This neural net can predict COVID-19-thrombosis at the time of hospital admission with a positive predictive value of 98%-100%.
Deciphering Abnormal Platelet Subpopulations in COVID-19, Sepsis and Systemic Lupus Erythematosus through Machine Learning and Single-Cell Transcriptomics

Xinru Qiu,Meera G Nair,Lukasz Jaroszewski,Adam Godzik

DOI: https://doi.org/10.3390/ijms25115941

IF: 5.6

2024-05-30

International Journal of Molecular Sciences

Abstract:This study focuses on understanding the transcriptional heterogeneity of activated platelets and its impact on diseases such as sepsis, COVID-19, and systemic lupus erythematosus (SLE). Recognizing the limited knowledge in this area, our research aims to dissect the complex transcriptional profiles of activated platelets to aid in developing targeted therapies for abnormal and pathogenic platelet subtypes. We analyzed single-cell transcriptional profiles from 47,977 platelets derived from 413 samples of patients with these diseases, utilizing Deep Neural Network (DNN) and eXtreme Gradient Boosting (XGB) to distinguish transcriptomic signatures predictive of fatal or survival outcomes. Our approach included source data annotations and platelet markers, along with SingleR and Seurat for comprehensive profiling. Additionally, we employed Uniform Manifold Approximation and Projection (UMAP) for effective dimensionality reduction and visualization, aiding in the identification of various platelet subtypes and their relation to disease severity and patient outcomes. Our results highlighted distinct platelet subpopulations that correlate with disease severity, revealing that changes in platelet transcription patterns can intensify endotheliopathy, increasing the risk of coagulation in fatal cases. Moreover, these changes may impact lymphocyte function, indicating a more extensive role for platelets in inflammatory and immune responses. This study identifies crucial biomarkers of platelet heterogeneity in serious health conditions, paving the way for innovative therapeutic approaches targeting platelet activation, which could improve patient outcomes in diseases characterized by altered platelet function.

biochemistry & molecular biology,chemistry, multidisciplinary
Abstract 11039: Platelets Contribute to Disease Severity in Covid-19

Tessa Barrett,Seda Bilaloglu,Macintosh Cornwell,Hannah Burgess,Vitor W De Moura Virginio,Kamelia Drenkova,Homam Ibrahim,Eugene Yuriditsky,Yindalon Aphinyanaphongs,Mark Lifshitz,Feng Xia Liang,Julie Alejo,Grace Smith,Stefania Pittaluga,Amy Rapkiewicz,Jun Wang,Camelia Iancu-Rubin,Ian Mohr,Kelly Ruggles,Kenneth Stapleford,Judith S Hochman,Jeffrey S Berger

DOI: https://doi.org/10.1161/circ.144.suppl_1.11039

IF: 37.8

2021-11-16

Circulation

Abstract:Objective: Heightened inflammation, dysregulated immunity, and thrombotic events are characteristic of hospitalized COVID-19 patients. Platelets are key regulators of thrombosis, inflammation, immunity and are prime candidates for a role in the pathogenesis of COVID-19. The objective of this study was to analyze the platelet phenotype in COVID-19. Approach and Results: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is detected in human megakaryocytes and platelets in COVID-19 patients and following incubation with the virus in vitro . We show a direct interaction between SARS-CoV-2 and megakaryocytes that alters the platelet transcriptome and platelet activity. COVID-19 platelets are hyperreactive and have a distinct transcriptomic profile characteristic of prothrombotic large and immature platelets. We find transcriptomic changes mediated by SARS-CoV-2 do not occur following exposure of megakaryocytes with a coronavirus responsible for the common cold, CoV-OC43. In a cohort of 3,915 hospitalized COVID-19 patients, we analyzed blood platelet indices collected at hospital admission. Following adjustment for demographics, clinical risk factors, medication use, and biomarkers of inflammation and thrombosis, platelet count, size, and immaturity are each associated with increased critical illness and all-cause mortality. Conclusions: Our findings demonstrate that SARS-CoV-2 virions invade megakaryocytes and platelets, inducing alterations to the platelet transcriptome and activation profile, which correlate with critical illness and mortality in hospitalized COVID-19 patients.

cardiac & cardiovascular systems,peripheral vascular disease
Abstract TMP49: Radiomics Model Predicts Histological Thrombus Composition on Admission CT Imaging

Maria Hernandez-Perez,Alba García Rey,Laura Dorado,Jesus M Juega,Víctor Salvia Punsoda,Jessica Camacho,Cristian Marti,Jorge Pagola

DOI: https://doi.org/10.1161/str.55.suppl_1.tmp49

IF: 10.17

2024-02-01

Stroke

Abstract:Background: Red blood cells (RBC)-rich thrombus are more easily retrieved via endovascular procedures while platelet-rich thrombus are more resistant to recanalization. Our aim was to generate a radiomics model able to identify both RBC and platelet-rich thrombus at CT admission in patients undergoing mechanical thrombectomy. Methods: We included consecutive patients that received mechanical thrombectomy due to a large vessel occlusion in which thrombi was obtained. Thrombi obtained during the procedure were hematoxiline-eosine processed and proportions of RBC were determined. Relative proportion of the platelets in the thrombi was quantified by using a immunohistochemical staining recognizing CD61. We considered RBC-rich thrombi those with a content of RBC>30% and platelet-rich thrombi those with a content of CD61>70%. Thrombi were segmented manually on co-registered non-contrast CT (NCCT) and CT angiography (CTA) at admission (<1mm thickness). 804 quantitative radiological features were extracted from the NCCT and CTA images. The most relevant features were selected with a genetic algorithm. Xgboost models were trained and one-versus-all cross-validated on the selected features to classify RBC and platelet-rich thrombi. Results: From 97 patients with histologically and radiologically available thrombi, 43% were female and mean age was 71(±12) years. The area under the curve for detecting RBC>30% was 0.938 (sensitivity 86%, specificity 86%, PPV 84%). Regarding platelet-rich thrombus, the area under the curve for detecting CD61>70% was 0.89 (sensitivity 83%, specificity 84%, PPV 74%). Feature importance by imaging type for RBC-rich and platelet rich thrombus was 70.33% and 69.8% for NCCT and 29.67% and 30% for CTA, respectively. The most important feature types for RBC-rich thrombus were histograms (51%) and first order (27%) while the most important features for platelet rich-thrombus were histograms (94%) followed by texture (5.94%). No information about shape improved any model. Conclusion: Our radiomics model can reliably identify RBC and platelet-rich thrombi. Fast identification of thrombus histological components on CT at arrival can help to design the preferred therapeutic strategy

peripheral vascular disease,clinical neurology
AI-based Analysis of CT Images for Rapid Triage of COVID-19 Patients.

Qinmei Xu,Xianghao Zhan,Zhen Zhou,Yiheng Li,Peiyi Xie,Shu Zhang,Xiuli Li,Yizhou Yu,Changsheng Zhou,Longjiang Zhang,Olivier Gevaert,Guangming Lu

DOI: https://doi.org/10.1038/s41746-021-00446-z

IF: 15.2

2021-01-01

npj Digital Medicine

Abstract:The COVID-19 pandemic overwhelms the medical resources in the stressed intensive care unit (ICU) capacity and the shortage of mechanical ventilation (MV). We performed CT-based analysis combined with electronic health records and clinical laboratory results on Cohort 1 (n = 1662 from 17 hospitals) with prognostic estimation for the rapid stratification of PCR confirmed COVID-19 patients. These models, validated on Cohort 2 (n = 700) and Cohort 3 (n = 662) constructed from nine external hospitals, achieved satisfying performance for predicting ICU, MV, and death of COVID-19 patients (AUROC 0.916, 0.919, and 0.853), even on events happened two days later after admission (AUROC 0.919, 0.943, and 0.856). Both clinical and image features showed complementary roles in prediction and provided accurate estimates to the time of progression (p < 0.001). Our findings are valuable for optimizing the use of medical resources in the COVID-19 pandemic. The models are available here: https://github.com/terryli710/COVID_19_Rapid_Triage_Risk_Predictor .
Deep Learning-Based Assessment of Cerebral Microbleeds in COVID-19

Neus Rodeja Ferrer,Malini Vendela Sagar,Kiril Vadimovic Klein,Christina Kruuse,Mads Nielsen,Mostafa Mehdipour Ghazi

DOI: https://doi.org/10.48550/arXiv.2301.09322

2023-01-23

Abstract:Cerebral Microbleeds (CMBs), typically captured as hypointensities from susceptibility-weighted imaging (SWI), are particularly important for the study of dementia, cerebrovascular disease, and normal aging. Recent studies on COVID-19 have shown an increase in CMBs of coronavirus cases. Automatic detection of CMBs is challenging due to the small size and amount of CMBs making the classes highly imbalanced, lack of publicly available annotated data, and similarity with CMB mimics such as calcifications, irons, and veins. Hence, the existing deep learning methods are mostly trained on very limited research data and fail to generalize to unseen data with high variability and cannot be used in clinical setups. To this end, we propose an efficient 3D deep learning framework that is actively trained on multi-domain data. Two public datasets assigned for normal aging, stroke, and Alzheimer's disease analysis as well as an in-house dataset for COVID-19 assessment are used to train and evaluate the models. The obtained results show that the proposed method is robust to low-resolution images and achieves 78% recall and 80% precision on the entire test set with an average false positive of 1.6 per scan.

Image and Video Processing,Computer Vision and Pattern Recognition,Machine Learning
Identification and validation of platelet-related diagnostic markers and potential drug screening in ischemic stroke by integrating comprehensive bioinformatics analysis and machine learning

Yifei Geng,Yuchen Liu,Min Wang,Xi Dong,Xiao Sun,Yun Luo,Xiaobo Sun

DOI: https://doi.org/10.3389/fimmu.2023.1320475

IF: 7.3

2024-01-10

Frontiers in Immunology

Abstract:Background: Ischemic stroke (IS), caused by blood and oxygen deprivation due to cerebral thrombosis, has links to activated and aggregated platelets. Discovering platelet-related biomarkers, developing diagnostic models, and screening antiplatelet drugs are crucial for IS diagnosis and treatment. Methods and results: Combining and normalizing GSE16561 and GSE22255 datasets identified 1,753 upregulated and 1,187 downregulated genes. Fifty-one genes in the platelet-related module were isolated using weighted gene co-expression network analysis (WGCNA) and other analyses, including 50 upregulated and one downregulated gene. Subsequent enrichment and network analyses resulted in 25 platelet-associated genes and six diagnostic markers for a risk assessment model. This model's area under the ROC curve outperformed single genes, and in the peripheral blood of the high-risk group, immune infiltration indicated a higher proportion of CD4, resting CD4 memory, and activated CD4 memory T cells, along with a lower proportion of CD8 T cells in comparison to the low-risk group. Utilizing the gene expression matrix and the CMap database, we identified two potential drugs for IS. Finally, a rat MACO/R model was used to validate the diagnostic markers' expression and the drugs' predicted anticoagulant effects. Conclusion: We identified six IS platelet-related biomarkers (APP, THBS1, F13A1, SRC, PPBP, and VCL) for a robust diagnostic model. The drugs alpha-linolenic acid and ciprofibrate have potential antiplatelet effects in IS. This study advances early IS diagnosis and treatment.

immunology
Machine learning algorithms utilizing blood parameters enable early detection of immunethrombotic dysregulation in COVID‐19

Zhaoming Zhou,Xiang Zhou,Liming Cheng,Lei Wen,Taixue An,Heng Gao,Hongrong Deng,Qi Yan,Xinlu Zhang,Youjiang Li,Yixing Liao,Xin‐zu Chen,Bin Nie,Jie Cheng,Guanhua Deng,Shengqiang Wang,Juan Li,Hanqi Yin,Mengxian Zhang,Linbo Cai,Lei Zheng,Minglun Li,Bleddyn Jones,Longhua Chen,Amir Abdollahi,Meijuan Zhou,Ping‐Kun Zhou,Cheng Zhou

DOI: https://doi.org/10.1002/ctm2.523

IF: 8.554

2021-09-01

Clinical and Translational Medicine

Abstract:FIGURE 1Open in figure viewerPowerPoint

oncology,medicine, research & experimental
At the Core: How We Steer Our Course

R. H. Klein

DOI: https://doi.org/10.1521/IJGP.55.2.229.62185

2005-03-01

International Journal of Group Psychotherapy

Abstract:Abstract The beautiful evocative words of Dylan Thomas speak to the driving life force that pulses through all creation. So what, then, drives our organization, the American Group Psychotherapy Association (AGPA)? What underlying stream can we tap into to provide the energy, power, and vitality we need to go on being in a meaningful and productive fashion? And, what internal compass can we rely on to steer us in the right direction, to guide us in how we function as an organization? My purpose here is to consider how we formulate our objectives, determine our priorities, make decisions, and insure, as best we can, that we are pursuing that which is meaningful and essential, not veering drastically off course. To do this, I would like to focus briefly on the current organizational structure of AGPA, then examine the use of a strategic planning process, review our accomplishments, and lastly explore hopes and dreams for our future as the premier group psychotherapy organization in the United States.
Interventional Removal of Travelling Microthrombi Using Targeted Magnetic Microbubble

Yongjian Li,Zujie Gao,Xiaobing Zheng,Yunfan Pan,Jinlong Xu,Yan Li,Haosheng Chen

DOI: https://doi.org/10.1002/adhm.202401631

IF: 10

2024-01-01

Advanced Healthcare Materials

Abstract:Microthrombus is one of the major causes of the sequelae of Corona Virus Disease 2019 (COVID-19 and leads to subsequent embolism and necrosis. Due to their small size and irregular movements, the early detection and efficient removal of microthrombi in vivo remain a great challenge. In this work, an interventional method is developed to identify and remove the traveling microthrombi using targeted-magnetic-microbubbles (TMMBs) and an interventional magnetic catheter. The thrombus-targeted drugs are coated on the TMMBs and magnetic nanoparticles are shelled inside, which allow not only targeted adhesion onto the traveling microthrombi, but also the effective capture by the magnetic catheter in the vessel. In the proof-of-concept experiments in the rat models, the concentration of microthrombus is reduced by more than 60% in 3 min, without damaging the organs. It is a promising method for treating microthrombus issues. The efficient removal microthrombus caused by COVID-19 and other pathogen, due to its tiny size and irregular movements, remains a great challenge. Using targeted antibodies and magnetic field manipulation, a novel minimally invasive in vivo microthrombus removal method is developed and designed. In both in vivo and in vitro experiments, the method demonstrates good clearance efficiency and safety. image

"A conscious control over life and my emotions:" mindfulness practice and healthy young people. A qualitative study.

Space Time-Based Optofluidic Imaging Analyser for Intelligent Blood Coagulation Diagnosis

Space-time-regulated Imaging Analyzer for Smart Coagulation Diagnosis.

Deep learning, 3D ultrastructural analysis reveals quantitative differences in platelet and organelle packing in COVID-19/SARSCoV2 patient-derived platelets

IP-10 and MCP-1 As Biomarkers Predicting Disease Severity of COVID-19

Finding and following: a deep learning-based pipeline for tracking platelets during thrombus formation in vivo and ex vivo

Convolutional neuronal network for identifying single‐cell‐platelet–platelet‐aggregates in human whole blood using imaging flow cytometry

Finding and Following: A deep learning-based pipeline for tracking platelets during thrombus formation and

Circulating cellular clusters are associated with thrombotic complications and clinical outcomes in COVID-19

Qualitative classification of thrombus images as a way to improve quantitative analysis of thrombus formation in flow chamber assays

Advancing Ischemic Stroke Diagnosis: A Novel Two-Stage Approach for Blood Clot Origin Identification

Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98

Deciphering Abnormal Platelet Subpopulations in COVID-19, Sepsis and Systemic Lupus Erythematosus through Machine Learning and Single-Cell Transcriptomics

Abstract 11039: Platelets Contribute to Disease Severity in Covid-19

Abstract TMP49: Radiomics Model Predicts Histological Thrombus Composition on Admission CT Imaging

AI-based Analysis of CT Images for Rapid Triage of COVID-19 Patients.

Deep Learning-Based Assessment of Cerebral Microbleeds in COVID-19

Identification and validation of platelet-related diagnostic markers and potential drug screening in ischemic stroke by integrating comprehensive bioinformatics analysis and machine learning

Machine learning algorithms utilizing blood parameters enable early detection of immunethrombotic dysregulation in COVID‐19

At the Core: How We Steer Our Course

Interventional Removal of Travelling Microthrombi Using Targeted Magnetic Microbubble